Catholic Community Services CReW Program

Located in Seattle, WA, Catholic Community Services CReW Program operates in WA's broader addiction-treatment market. The facility offers a continuum of care across multiple levels — Outpatient, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. What this page tries to do is frame the specific questions worth asking, which are rarely the ones that get asked first.

Care levels at Catholic Community Services CReW Program

What Catholic Community Services CReW Program offers: The facility offers a continuum of care across multiple levels — Outpatient, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. What matters is whether that matches the specific clinical picture, which only a proper assessment can tell. Most mismatches happen when the assessment is skipped or done inside the facility with a commercial interest in admission.

Insurance and payment

Catholic Community Services CReW Program accepts Medicaid — which is consequential because facilities that accept Medicaid tend to have the broadest patient populations and the most developed public-sector relationships, though reimbursement structures mean program intensity sometimes differs from commercial-focused centers. Most post-treatment billing disputes trace back to a specific moment when an admissions counselor said one thing and the benefits department later documented something else. Avoid the moment by getting the written VOB before admission, not after.

Before you call

Questions that matter before admitting to Catholic Community Services CReW Program: ASAM level of care (not the facility's category, the clinical level); written VOB; MAT policy. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. The ones who answer those quickly are usually the ones worth considering. The ones who dodge are almost always worth skipping.